Previous pilot studies, including ours, have reported suppressed interleukin-6, hs-CRP, MCP-1, myeloperoxidase (MPO), decreased oxidative injury of red blood cells and lymphocytes, improved redox status of serum albumin, and amelioration of hypertension [19–25]. Here, MPO is linked to hypertensive disorder.